Goldman Sachs
ALIM

Goldman Sachs’s Alimera Sciences ALIM Stock Holding History

Goldman Sachs’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-33,333
Closed -$875K – 7291
2016
Q1 		$875K Buy
+33,333
New +$1.04M ﹤0.01% 4190
2015
Q4 		– Sell
-83,333
Closed -$2.76M – 7381
2015
Q3 		$2.76M Buy
+83,333
New +$4.69M ﹤0.01% 3449
2015
Q2 		– Sell
-3,333
Closed -$251K – 7473
2015
Q1 		$251K Sell
3,333
-5,914
-64% -$465K ﹤0.01% 5817
2014
Q4 		$768K Sell
9,247
-15,386
-62% -$1.25M ﹤0.01% 4860
2014
Q3 		$2M Buy
24,633
+12,366
+101% +$1.06M ﹤0.01% 3931
2014
Q2 		$1.1M Buy
12,267
+6,520
+113% +$579K ﹤0.01% 4605
2014
Q1 		$680K Buy
+5,747
New +$558K ﹤0.01% 5014

Other funds holding ALIM

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs's ALIM Position: Q2 2024 in Review

Goldman Sachs sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 71,758 shares — an estimated $280K sold.

Goldman Sachs first reported a position in ALIM in Q4 2013 and held it in 21 quarters. The position peaked at $3.91M in Q4 2015. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Goldman Sachs reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 71,758 Alimera Sciences shares in Q2 2024, an estimated $280K.
  • Goldman Sachs first reported a position in Alimera Sciences in Q4 2013 and held it in 21 quarters.
  • Goldman Sachs's Alimera Sciences position peaked at $3.91M in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.